Paul Tudor Jones's LEGN Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 29,066 shares of Legend Biotech Corporation (LEGN) worth $839,426, representing 0.00% of the portfolio. First purchased in 2020-Q2, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in LEGN, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 72,060 shares. Largest reduction occurred in Q2 2026, reducing 26,036 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Legend Biotech Corporation (LEGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Legend Biotech Corporation (LEGN) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -26,036 | Reduce 47.25% | 29,066 | $28.88 |
| Q1 2026 | +1,802 | Add 3.38% | 55,102 | $18.09 |
| Q4 2025 | +628 | Add 1.19% | 53,300 | $21.74 |
| Q3 2025 | +3,167 | Add 6.40% | 52,672 | $32.61 |
| Q2 2025 | -22,555 | Reduce 31.30% | 49,505 | $35.49 |
| Q1 2025 | +72,060 | New Buy | 72,060 | $33.93 |
| Q4 2024 | -5,572 | Sold Out | 0 | $0.00 |
| Q3 2024 | +5,572 | New Buy | 5,572 | $48.73 |
| Q3 2020 | -8,771 | Sold Out | 0 | $0.00 |
| Q2 2020 | +8,771 | New Buy | 8,771 | $42.53 |
Paul Tudor Jones's Legend Biotech Corporation Investment FAQs
Paul Tudor Jones first purchased Legend Biotech Corporation (LEGN) in Q2 2020, acquiring 8,771 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Legend Biotech Corporation (LEGN) for 10 quarters since Q2 2020.
Paul Tudor Jones's largest addition to Legend Biotech Corporation (LEGN) was in Q1 2025, adding 72,060 shares worth $2.44 M.
According to the latest 13F filing for Q2 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 29,066 shares of Legend Biotech Corporation (LEGN), valued at approximately $839,426.
As of the Q2 2026 filing, Legend Biotech Corporation (LEGN) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Legend Biotech Corporation (LEGN) was 72,060 shares, as reported at the end of Q1 2025.